The IVF market in Europe is characterized by factors such as lower fertility rates, delayed marriages, and late parenthood decisions. Subsidization of IVF treatments in Germany owing to the lowest birthrate of ~1.46 children/women is a major driving factor for the growth of this market.
The IVF Market in Europe is anticipated to witness a continued stable growth, mainly in France, Germany, and UK. This is due to supportive regulations such as Human Fertilization and Embryo authority (HFEA) of UK, which closely regulate the functioning of IVF treatments and research in UK.
The European market was valued at $3,054 million in 2015 and is expected to reach $4,447 million by 2022, growing at a CAGR of 5.4% from 2016 to 2022. The fresh cycle (non-donor) segment accounted for more than three-fourths market share in 2015 and is expected to maintain its dominance during the forecast period.
The growing trends of delayed pregnancy have steadily increased across Europe and other countries. In older women, eggs produced by the reproductive system are less efficient for the process of fertilization with the male spermatozoa, resulting in risk of genetic disorders. According to Centers for Disease Control and Prevention (CDC), the rate of fertilization in the age group of 35‐39 years through IVF is considerably high.
Get the PDF brochure of this market insight@ https://www.alliedmarketresearch.com/request-sample/1823
IVF techniques play a significant role in addressing infertility. The success rates in Denmark range from 26% to 29% for patients in the age group of 25‐37 years. The pregnancy rate is 12‐16% for the age group of 37‐45 years; however, clinicians claim that there are more chances of miscarriage in this age group, resulting in birth rate of about 8‐10%. A single standard IVF cycle in Denmark costs approximately $4,800, which is less than that in the rest of European countries. However, these costs are higher as compared to that in Russia and Spain.
Europe IVF Market Key Findings
- Fertility clinics segment is projected to grow at the highest CAGR during the forecast period.
- UK is expected possess the highest growth rate in the European IVF market, growing at a CAGR of 7.7%, in terms of revenue.
- In 2015, EU5 (Germany, France, UK, Spain, and Italy) collectively accounted for the approximately three-fifths share of the market volume.
- Fresh cycle (non-donor) segment is expected be the highest revenue-generating segment, followed by thawed IVF cycle (non-donor) segment.
- Thawed IVF cycle (non-donor) segment is projected to grow at the highest CAGR of 7.2%, in terms of volume in Denmark.